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DUSP6 (dual-speciﬁcity phosphatase 6), also known as MKP-3
[MAPK (mitogen-activated protein kinase) phosphatase-3] speci-
ﬁcally inactivates ERK1/2 (extracellular-signal-regulated kinase
1/2) in vitro and in vivo. DUSP6/MKP-3 is inducible by FGF
(ﬁbroblast growth factor) signalling and acts as a negative regu-
lator of ERK activity in key and discrete signalling centres that
directoutgrowthandpatterninginearlyvertebrateembryos.How-
ever, the molecular mechanism by which FGFs induce DUSP6/
MKP-3 expression and hence help to set ERK1/2 signalling
levels is unknown. In the present study, we demonstrate, using
pharmacological inhibitors and analysis of the murine DUSP6/
MKP-3 gene promoter, that the ERK pathway is critical for FGF-
induced DUSP6/MKP-3 transcription. Furthermore, we show
that this response is mediated by a conserved binding site
for the Ets (E twenty-six) family of transcriptional regulators
and that the Ets2 protein, a known target of ERK signalling,
binds to the endogenous DUSP6/MKP-3 promoter. Finally, the
murine DUSP6/MKP-3 promoter coupled to EGFP (enhanced
green ﬂuorescent protein) recapitulates the speciﬁc pattern of
endogenous DUSP6/MKP-3 mRNA expression in the chicken
neural plate, where its activity depends on FGFR (FGF receptor)
and MAPK signalling and an intact Ets-binding site. These
ﬁndings identify a conserved Ets-factor-dependent mechanism
by which ERK signalling activates DUSP6/MKP-3 transcription
to deliver ERK1/2-speciﬁc negative-feedback control of FGF
signalling.
Key words: dual-speciﬁcity phosphatase 6 (DUSP6), ﬁbroblast
growth factor (FGF), mitogen-activated protein kinase (MAPK),
mitogen-activated protein kinase phosphatase-3 (MKP-3),
phosphatase, transcription.
INTRODUCTION
DUSP (dual-speciﬁcity phosphatase) 6 or MKP [MAPK
(mitogen-activated protein kinase) phosphatase]-3 is the proto-
typical member of a subfamily of three cytoplasmic MKPs,
which also includes DUSP7/MKP-X and DUSP9/MKP-4 [1,2].
These enzymes all display a high degree of substrate selectivity
for the ERKs (extracellular-signal-regulated kinases) 1 and 2
in vitro and in vivo [3,4]. Speciﬁc recognition and binding to
ERK2 is mediated by a conserved KIM (kinase interaction motif)
within the N-terminal non-catalytic domain of DUSP6/MKP-3
and this region of the protein also contains a conserved NES
(nuclear export signal), which is responsible for the cytoplasmic
localization of this phosphatase [5,6]. The speciﬁcity of DUSP6/
MKP-3 for dephosphorylation and inactivation of the ERK1 and
ERK2 MAPKs is enhanced further by ERK-induced conformat-
ional change within the catalytic domain of MKP-3, which leads
to greatly enhanced phosphatase activity in vitro [7,8].
TheﬁrstcluesastothephysiologicalroleofMKP-3camefrom
the observation that DUSP6/MKP-3 mRNA is expressed at many
sites of FGF (ﬁbroblast growth factor) signalling in developing
mouse and chicken embryos. These include the limb bud
and branchial arch mesenchyme, midbrain/hindbrain isthmus,
hair and mammary placodes [9], and early neural plate [10].
Further experiments involving tissue ablation and transplantation
in chicken embryos identiﬁed the AER (apical ectodermal
ridge) and Hensen’s node as tissue sources of FGF which
are essential for the expression of DUSP6/MKP-3 in the
developing limb bud and neural plate respectively [10,11]. In
addition, FGF signalling is also responsible for the expression of
DUSP6/MKP-3 in the murine isthmic organizer during neural
tube development and in developing chick somites [12,13].
These studies suggest that DUSP6/MKP-3 is a negative regulator
of FGF signalling during vertebrate development, which may
work to set the levels of ERK signalling downstream of this
signallingpathway.Thisconclusionissupportedbytheresultsofa
recentmouseknockoutexperiment.DUSP6/MKP-3-nullembryos
display elevated ERK phosphorylation in limb bud mesenchyme
and present with variably penetrant skeletal dwarﬁsm, premature
fusion of cranial sutures (craniosynostoses) and deafness, all of
which are consistent with increased levels of FGF signalling
[14].
Abbreviations used: AER, apical ectodermal ridge; ChIP, chromatin immunoprecipitation; ConA, concanavalin A; DMEM, Dulbecco’s modiﬁed Eagle’s
medium; DUSP, dual-speciﬁcity phosphatase; EGFP, enhanced green ﬂuorescent protein; Elk1, Ets-like kinase 1; EMSA, electrophoretic mobility-shift
assay; ER, oestrogen receptor; ERK, extracellular-signal-regulated kinase; Ets, E twenty-six; FBS, fetal bovine serum; FGF, ﬁbroblast growth factor; FGFR,
FGF receptor; FKHD, Forkhead mutant; βGal, β-galactosidase; HA, haemagglutinin; HH10, Hamburger and Hamilton stage 10; 4-HT, 4-hydroxytamoxifen;
IκBα, inhibitor of nuclear factor κB α; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase; MKK, MAPK kinase;
MKKK, MAPK kinase kinase; MKP, MAPK phosphatase; mRFP, monomeric red ﬂuorescent protein; NF-κB, nuclear factor κB; PBX1, pre-B-cell leukaemia
transcription factor 1; PI3K, phosphoinositide 3-kinase; RSV, rous sarcoma virus; SRF, serum-response factor; SRY, sex-determining region Y; TNFα, tumour
necrosis factor α.
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Although the link between FGF signalling and DUSP6/MKP-3
expressionisnowwellestablished,theprecisemolecularmechan-
ism by which this occurs is unknown. In particular, it is unclear
whichoftheintracellularsignallingpathwaysthatliedownstream
of the FGFR (FGF receptor) is responsible for mediating DUSP6/
MKP-3 transcription, with essential roles proposed for both
the ERK and PI3K (phosphoinositide 3-kinase) pathways [10–
13,15]. The majority of these data were obtained in a variety
of embryonic tissues often using different pharmacological
inhibitors of these pathways and this may account for some of
the contradictory data obtained [16].
In the present study, we have used a cell culture model to over-
come the limitations of drug delivery using bead implantation in
chicken embryos to address the nature of the intracellular sig-
nalling pathways involved in FGF-mediated DUSP6/MKP-3 ex-
pression. This has been combined with a bioinformatic and func-
tional dissection of the DUSP6/MKP-3 gene promoter and has
enabled us to deﬁne a mechanism by which signalling though
the ERK MAPK pathway interacts with a conserved regulatory
regionwithintheproximalpromoterofthegenetoeffectnegative-
feedback control of FGF signalling in vitro and in the developing
chick embryo.
EXPERIMENTAL
Reagents
Recombinant human FGF2 (basic FGF), human FGF4 and
mouse FGF8b were purchased from R&D Systems. SU5402
and LY294002 were from Calbiochem. PD184352 was kindly
provided by Professor Sir Philip Cohen (MRC Protein
Phosphorylation Unit, University of Dundee). Antibodies
against ERK, phospho-ERK, p38, phospho-p38, JNK (c-Jun N-
terminal kinase), phospho-JNK and phospho-Akt were purchased
from Cell Signaling Technology. The antisera raised against
Ets (E twenty-six) family proteins were from Santa Cruz
Biotechnology. The polyclonal antibody against DUSP6/MKP-3
was raised in sheep using puriﬁed recombinant DUSP6/
MKP-3 protein as an antigen. The speciﬁcity and sensitivity of
this antiserum was veriﬁed by immunoblotting of recombinant
DUSP6/MKP-3, its ability to recognize DUSP6/MKP-3, but
not the related phosphatases encoded by DUSP7 and DUSP9,
when expressed in Cos-1 cells and Western blotting of protein
lysates from wild-type and DUSP6-knockout mouse embryos
(resultsnotshown).ReagentswerepurchasedfromSigma,unless
indicated otherwise. All tissue culture reagents were obtained
from Invitrogen.
Cell lines and tissue culture
NIH 3T3 cells were maintained in DMEM (Dulbecco’s modiﬁed
Eagle’s medium) supplemented with 10% newborn calf serum,
penicillin(100 units/ml)andstreptomycin(100 units/ml). -Raf-
1:ER* NIH 3T3 cells [NIH 3T3 ﬁbroblasts that stably express a
fusion between a constitutively active form of the Raf-1 MKKK
(MAPK kinase kinase) and a mutant form of the ER (oestrogen
receptor)] were maintained in Phenol Red-free DMEM contain-
ing glucose (4500 mg/l), penicillin (100 units/ml), streptomycin
(100 units/ml), 2 mM glutamine and 10% FBS (fetal bovine
serum) supplemented with 2 μg/ml puromycin.  -Raf-1:ER*
NIH 3T3 cells were induced with either 10 nM or 100 nM 4-HT
(4-hydroxytamoxifen) as indicated. For inhibitor studies, cells
were cultured in Petri dishes for 48 h and were serum-starved
overnight. Inhibitors SU5402 (50 μM), PD184352 (2 μM) and
LY294002 (10 μM) were added 30 min before the addition of
FGFs (30 ng/ml) and cells were then incubated for an addi-
tional 5 h. Cells were lysed, and proteins were analysed using
the NuPAGE electrophoresis system (4–12%) (Invitrogen) and
Western blotting. For analysis of DUSP6/MKP-3 mRNA levels,
RNAwasisolatedfromcellsusinganRNeasykit(Qiagen)accord-
ing to the manufacturer’s instructions, and 200 ng of RNA was
reverse-transcribed in a ﬁnal volume of 50 μl using Taqman re-
versetranscriptionreagents(AppliedBiosystems).A4 ngsample
of cDNA was analysed by quantitative PCR using pre-developed
assay primers and probes for DUSP6/MKP-3 (Mm00650255_g1;
Applied Biosystems). Real-time PCR was performed in the pre-
sence of 0.6× Taqman Universal PCR mix (Applied Biosystems)
under the following conditions: 50◦Cf o r2m i n ,9 5◦C for 10 min,
92◦C for 15 s and 60◦C for 1 min using an ABI Prism 7700
sequence detector. Fluorescence output was directly proportional
to the concentration of input cDNA and was normalized against
β-actin (Mm00607939_s1).
Analysis of the DUSP6/MKP-3 promoter in silico
TheupstreamgenomicsequenceofDUSP6/MKP-3wasinspected
within the February 2006 (NCBI build 36) assembly of the
murine genome using the UCSC genome browser [17], and a
candidate region was selected such that the maximum number
of vertebrate species genomes aligned to the mouse. The cor-
responding multiple species alignment was extracted using the
Vertebrate Multiz Alignment & Conservation track [18] within
the UCSC genome browser. The alignments were then
screened for conserved transcription factor-binding sites using
MatInspector [19] and a vertebrate factor subset of Genomatix’s
proprietary database.
Luciferase reporter assays
Cells were transfected with luciferase reporters using Lipo-
fectamine
TM Plus (Invitrogen). At 3 h post-transfection, cells
were starved overnight in 0.5% serum. The following day, cells
were stimulated with FGFs (all at 30 ng/ml) either alone or
together with the indicated inhibitors and then incubated for
an additional 24 h before the DLR (Dual-Luciferase® Reporter)
Assay (Promega) was performed according to the manufacturer’s
instructions. pGL3Basic was used as a negative (no promoter)
control and pRL-TK Renilla was used to normalize for trans-
fection efﬁciency (Promega). A 6400 bp BamHI/BamHI genomic
fragment lying upstream of the DUSP6/MKP-3 start codon
and including the putative transcriptional start site was cloned
into pGL3Basic. This full-length promoter was used as a
template in PCRs to generate deletion mutants, which were
subsequently cloned into pGL3Basic as KpnI/BamHI fragments.
Point mutations within the DUSP6/MKP-3 promoter were
introduced into the 508 bp promoter–reporter construct. Ets-
binding mutants were made using complementary primers
5
 -CTTATCCGGAGCGGAAATTCCTTTC-3
  in which the
central core Ets-binding site GGA (underlined) was mutated to
TTC (triple mutant) as described by Withers and Hakomori [20],
or as single mutants TGA (ﬁrst base), GTA (second base) or GGC
(third base) respectively. The palindromic Ets-binding site TCC
(underlined) was altered to GAA using complementary primers
5
 -GGAGCGGAAATGAATTTCCGTTTTTG-3
 . The Forkhead
mutant (FKHD) was made using complementary primers
5
 -GTTGCAGCTTGTTTGCACTGGG-3
  in which the central
FKHD-binding site (underlined) was altered to CCCC. Wild-
type and mutant (Ets2  410–425 and Ets2 T72A) forms of
Ets2 were expressed as HA (haemagglutinin) epitope-tagged
proteins in the mammalian expression vector pcDNA3. The
NF-κB (nuclear factor κB) reporter construct 3× κB–ConA
(concanavalin A)–luciferase (3× κB), its control (lacking the
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NF-κB-binding sites) ConA–luciferase (ConA) and the RSV
(rous sarcoma virus) expression vectors encoding the dominant-
negative IκBα (inhibitor of NF-κB α) mutant (RSV-Mad3) and
β-galactosidase (RSV-βGal) were kindly provided by Dr Neil
Perkins (University of Dundee).
EMSA (electrophoretic mobility-shift assay) and ChIP (chromatin
immunoprecipitation) assays
32P-labelled probes were generated by annealing complementary
oligonucleotide pairs which generate 5
  →3
  overhangs and sub-
sequentradiolabellingbyincubationwithKlenowpolymeraseand
[α-
32P]dCTP. Probes were puriﬁed on Probequant G-50 columns
(GE Healthcare) according to the manufacturer’s instructions.
Oligonucleotides used were MKP-3 (wild-type), 5
 -GGGCT-
TATCCGGAGCGGAAATTCCTTT-3
  and 5
 -CGGAAAGGA-
ATTTCCGCTCCGGATAAG-3
 ; MKP-3m (Ets-site mutant),
5
 -GGGCTTATCCGGAGCTTCAATTCCT-3
  and5
 -CGGAAA-
GGAATTGAAGCTCCGGATAG-3
 ; E74 (canonical wild-type
Ets site), 5
 -GGAGCTGAATAACCGGAAGTAACTCAT-3
  and
5
 -GGGATGAGTTACTTCCGGTTATTCAGC-3
 ; E74m (mu-
tant Ets site), 5
 -GGAGCTGAATAACCGTAAGTAACTCAT-3
 
and 5
 -GGGATGAGTTACTTACGGTTATTCAGC-3
 . Nuclear
extracts were prepared and EMSAs were performed exactly as
described by Feng et al. [21].
ChIPassayswereperformedexactlyasdescribedbyBoydetal.
[22]. Brieﬂy, approx. 10
7 NIH 3T3 cells were used per immuno-
precipitation. Following sonication, 100 μl of chromatin samples
were diluted in 1 ml of buffer containing 0.1% SDS, 167 mM
NaCl,1.1%(v/v)TritonX-100,1 mMEDTA,16.7 mMTris/HCl
(pH 8.0) with protease inhibitors and pre-cleared twice for 1 h at
4◦Cwith25 μlofProteinGsaturatedwithBSAandsalmonsperm
DNA (Upstate). Pre-cleared samples were then immunopre-
cipitated overnight with 2 μg of the anti-Ets1 (sc350x), anti-Ets2
(sc351x), anti-Erm81 (sc22807x) and the unrelated anti-HA
(sc805x) antibodies (all Santa Cruz Biotechnology) in the
presence of 20 μl of pre-blocked Protein G. Immune complexes
werewashedﬁvetimesinmodiﬁedRIPAbuffer[20 mMTris/HCl
(pH 8.0),1 mMEDTA,1%(v/v)NonidetP40,0.4 MLiCl,0.7%
sodium deoxycholate and protease inhibitors]. The DNA was
then eluted in TE (10 mM Tris/HCl and 1 mM EDTA, pH 7.5)
containing 1% (w/v) SDS, incubated overnight at 55◦Ci nt h e
presence of proteinase K (100 μg/ml) and puriﬁed using a PCR
puriﬁcation column (Qiagen). PCRs (40 μl volumes) consisting
of30cyclesof95◦Cfor30 s,52◦Cfor30 sand72◦Cfor30 swere
carried out using 3 μl of eluted DNA as the template and either
ChIPFO2, 5
 -TGTGAACTCTAAACAGAAGGAAACAC-3
 ,
and ChIPRE2, 5
 -ACAGGTTGTGTTGATGAATTGTTAAT-3
 ,
whichamplifynucleotides−555to−764containingtheputative
Ets site, or, as a control, ChIPFO3, 5
 -CAGCGACTGGAATGA-
GAACA-3
 , and ChIPRE3, 5
 -GGTGCCTGATTAACCCT-
TGA-3
 , which amplify nucleotides +330 to +550 lying
downstream of the Ets-binding site. PCR products were analysed
using a 2% agarose gel run in 0.5× TBE (Tris/borate/EDTA)
and stained with ethidium bromide.
Embryo culture and electroporation
Thewild-type508 bpDUSP6/MKP-3promoterfragment,andthe
corresponding Ets site (GGA to TTC) and FKHD (TGTT to
CCCC)weresubclonedintoanEGFP(enhancedgreenﬂuorescent
protein)-expressing plasmid ptkd2EGFP [23] as KpnI/BglII
fragments. Fertile hen’s eggs (High Sex×Rhode Island Red)
were incubated at 38◦C to yield embryos of Hamburger and
Hamilton stage 10 (HH10, ten somite) [23a]. Electroporation
with appropriate constructs was carried out in ovo using
standard techniques [24] and ﬂuorescence was monitored after
4 h. For bead experiments, embryos were put in culture [25],
electroporated as described in [10] and incubated for 1 h before
beads (pre-soaked for 1 h) presenting inhibitors (5 mM SU5402,
20 mM PD184352, 20 mM LY294002 or DMSO vehicle) were
implanted next to the caudal neural plate. Embryos were left to
develop for 4–5 h in a humidiﬁed 38◦C incubator before being
checkedforﬂuorescenceandphotographedbeforeﬁxationin4%
(w/v) paraformaldehyde in PBS overnight at 4◦C.
In situ hybridization and immunocytochemistry of chick embryos
A standard in situ hybridization protocol was used to detect
DUSP6/MKP-3 mRNA in the chick embryo [10]. Whole-embryo
immunocytochemistry to detect dual-phosphorylated and activ-
atedERK1/2wascarriedoutasdescribedpreviouslyusingananti-
dpERK1/2 (dual-phosphorylated ERK1/2) antibody from Cell
Signaling Technology [26].
RESULTS
DUSP6/MKP-3 is an FGF-inducible protein in NIH 3T3 cells
Studiesinvertebrateembryoshaveprovidedcompellingevidence
fortheinvolvementofFGFR-mediatedsignallingintheinduction
of DUSP6/MKP-3 mRNA expression during early development.
However, it is uncertain exactly how this occurs with studies
invoking essential roles for both ERK and PI3K in mediating this
response.
To dissect the molecular mechanisms underlying FGF-
inducibleDUSP6/MKP-3expressioninahighlytractablesystem,
we screened a panel of mammalian cell lines for expression of
the protein. Detectable levels of DUSP6/MKP-3 were seen in
HepG2 (human hepatoma) cells and mouse NIH 3T3 ﬁbroblasts.
In contrast, DUSP6/MKP-3 was absent in Cos-1, HeLa and
HEK-293T (human embryonic kidney) cells (results not shown).
Because NIH 3T3 cells have been widely used in studies of in-
ducible gene expression, we determined whether levels of
DUSP6/MKP-3 are increased following FGF treatment (Fig-
ure 1A). Elevated levels of DUSP6/MKP-3 protein were detected
following exposure to FGF2, FGF4 and FGF8, and this correlated
with increased phosphorylation of ERK2. In contrast, none of the
FGF treatments led to phosphorylation of either p38 or JNK. We
note that DUSP6/MKP-3 is resolved as a doublet in these
immunoblots.Thisreﬂectstheuseofalternativetranslationalstart
sites (at codons 1 and 14) within the DUSP6/MKP-3 mRNA [27].
Exposure of mouse ﬁbroblasts to FGF was shown previously
to result in activation of both ERK1/2 and PI3K [28]. Consistent
withthis,weobservedincreasedphosphorylationofbothERK1/2
and the Akt protein kinase, a downstream target of the PI3K
pathway, in response to FGF2. Phosphorylation of both ERK and
Akt was apparent 30 min after addition of FGF2, reached peak
levels after 1 h and declined thereafter (Figure 1B, upper panels).
As expected, Akt phosphorylation was abolished by LY294002
(10 μM), a speciﬁc inhibitor of PI3K signalling (Figure 1B,
lower panel). Elevated levels of DUSP6/MKP-3 protein were
detected approx. 1 h after exposure to FGF2 and persisted for at
least 8 h (Figure 1B, upper panel) while DUSP6/MKP-3 mRNA
levels were increased within 30 min of FGF exposure, reached
maximum levels after approx. 90 min and declined thereafter
(Figure 1C).
FGF-dependent activation of ERK2, but not PI3K, is essential for
induction of DUSP6/MKP-3 mRNA and protein
To dissect the signalling events responsible for FGF-inducible
DUSP6/MKP-3 expression, we have employed chemical
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Figure 1 The expression of DUSP6/MKP-3 mRNA and protein is inducible
by FGF in NIH 3T3 cells
(A) NIH 3T3 cells were serum-starved overnight before exposure to FGF2, FGF4 or FGF8 (all at
30ng/ml)for5 h.Cellswerethenlysed,andproteinswereanalysedbySDS/PAGEandWestern
blotting using antisera against MKP-3, phospho-ERK (P-ERK), ERK, phospho-p38 (P-p38),
p38, phospho-JNK (P-JNK) and JNK. (B) NIH 3T3 cells were serum-starved overnight and
then exposed to FGF2 (30ng/ml) for the indicated time before lysis and analysis of proteins by
SDS/PAGE and Western blotting using antisera against MKP-3, phospho-ERK (P-ERK), ERK,
phospho-Akt (P-Akt) or Akt (upper panels). NIH 3T3 cells were serum-starved overnight and
then exposed to FGF2 (30ng/ml) for the times indicated in either the absence or the presence
of the PI3K inhibitor LY294002 (10μM) before lysis and analysis of proteins by SDS/PAGE
and Western blotting using antisera against phospho-Akt (P-Akt) or Akt (lower panel). (C)N I H
3T3 cells were serum-starved overnight before exposure to FGF2 (30ng/ml) for the times indi-
cated. Cells were then lysed, and cellular RNA was prepared. DUSP6/MKP-3 mRNA levels
were then analysed using real-time PCR. Assays were performed in triplicate and relative
DUSP6/MKP-3 mRNA levels are presented as means+ −S.E.M.
inhibitors at concentrations where speciﬁcity is optimal. First,
cells were treated with SU5402 (50 μM), a speciﬁc FGFR inhib-
itor [29], and then exposed to FGFs for 5 h (Figure 2A). As
expected, this drug blocked both the FGF-dependent phosphoryl-
ation of ERK and phosphorylation of the Akt protein kinase, a
target of the PI3K pathway. SU5402 also blocked the induction
of DUSP6/MKP-3 protein by FGF2, FGF4 and FGF8, clearly
demonstratingarequirementforFGFRactivationinthisresponse.
We next employed the speciﬁc MEK (MAPK/ERK kinase) inhib-
itor PD184352 (2 μM), which is a more speciﬁc and potent
inhibitoroftheMAPKpathwaythanPD98059[30,31].Incontrast
with SU5402, this drug did not affect phosphorylation of Akt, but
completely blocked the FGF-mediated activation of ERK1/2 and
the induction of DUSP6/MKP-3 protein (Figure 2B).
LY294002 (10 μM) had no effect on either FGF-induced
ERK activation or DUSP6/MKP-3 expression, but, as expected,
it caused a dramatic reduction in the levels of phospho-Akt
(Figure 2C). In addition to these inhibitors, we also determined
that FGF-mediated induction of DUSP6/MKP-3 was unaffected
by inhibition of either the TOR (target of rapamycin) pathway
using rapamycin (100 nM) or phospholipase C activity using
U-73122 (4 μM) (results not shown). Finally, we used real-time
PCRtomeasurerelativelevelsofDUSP6/MKP-3mRNAinFGF-
treated NIH 3T3 cells in the absence and presence of either
PD184352 or LY294002. Clearly, inhibition of the ERK MAPK
pathway, but not PI3K activity, blocks FGF-inducible DUSP6/
MKP-3 mRNA expression (Figure 2D).
Figure 2 The induction of DUSP6/MKP-3 protein and mRNA by FGFs is
blocked by chemical inhibitors of either the FGFR tyrosine kinase or MEK,
but not by a speciﬁc inhibitor of PI3K activity in NIH 3T3 cells
NIH 3T3 cells were serum-starved overnight before exposure to FGF2, FGF4 or FGF8 (all at
30ng/ml)for5heitherintheabsence(DMSOvehicleonly)orpresenceof(A)theFGFRinhibitor
SU5402(50μM),(B)theMEKinhibitorPD184352(2μM)or(C)thePI3KinhibitorLY294002
(10μM). Cell lysates were analysed by SDS/PAGE and Western blotting using antisera against
MKP-3, phospho-ERK (P-ERK), ERK, phospho-Akt (P-Akt) and Akt. (D) NIH 3T3 cells were
serum-starved overnight before exposure to FGF2, FGF4 or FGF8 (all at 30 ng/ml) for 90min
in either the absence (DMSO vehicle only) or the presence of the indicated inhibitor. Cells were
then lysed, and cellular RNA was prepared. DUSP6/MKP-3 mRNA levels were then analysed
using real-time PCR. Assays were performed in triplicate and relative DUSP6/MKP-3 mRNA
levels are presented as means+ −S.E.M.
ERK1/2 activation is both necessary and sufﬁcient for induction of
DUSP6/MKP-3
Although the experiments described above indicate that
ERK signalling is essential for FGF-mediated induction of
DUSP6/MKP-3, we wished to know whether activation of ERK
alone is sufﬁcient to trigger expression of this gene. To address
this question, we obtained mouse NIH 3T3 ﬁbroblasts that stably
express a fusion between a constitutively active form of the Raf-1
MKKK and a mutant form of the ER ( -Raf-1:ER* NIH 3T3
cells). These  -Raf-1:ER* NIH 3T3 cells respond to 4-HT by
activation of Raf, which selectively activates MKK (MAPK
kinase), thus causing activation of ERK [32]. Treatment of
 -Raf-1:ER* NIH 3T3 cells, but not parental wild-type NIH
3T3 cells with 4-HT (10 or 100 nM) leads to ERK activation
and induction of DUSP6/MKP-3, whereas both cell lines respond
normally to FGF4 (Figure 3A). As expected, both the induction
of DUSP6/MKP-3 and activation of ERK in response to 4-HT
are blocked by PD184352, but are insensitive to inhibition of
FGFR activity bySU5402(Figure3). Weconcludethat activation
of ERK is both necessary and sufﬁcient to trigger expression of
DUSP6/MKP-3.
The murine DUSP6/MKP-3 promoter contains a conserved region
that is required for FGF-responsive transcription
The use of comparative genome analysis to detect non-coding
DNA sequence conservation within the 5
 -ﬂanking regions of
orthologous genes across species is a useful tool in the identi-
ﬁcationofkeyregulatoryelements[33].Ananalysisofthisregion
of the DUSP6/MKP-3 genes from mouse, rat, human, Xenopus,
zebraﬁshandFuguidentiﬁedahighlyconservedregionextending
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Figure 3 ERK activation is both necessary and sufﬁcient for the induction
of DUSP6/MKP-3 protein in NIH 3T3 cells
(A) Either  -Raf-1:ER* NIH 3T3 cells ( -Raf 3T3) or NIH 3T3 cells were serum-starved
overnight and then exposed to the indicated concentration of 4-HT in either the absence or
the presence of PD184352 (PD; 2μM). As a control, cells were exposed to FGF4 (30ng/ml).
After5 hofincubation,cellswerelysed,andproteinswereanalysedbySDS/PAGEandWestern
blotting using antisera against MKP-3, phospho-ERK (P-ERK) and ERK. (B)  -Raf-1:ER* NIH
3T3 cells were serum-starved overnight and then exposed to either the indicated concentration
of4-HTorFGF4(30ng/ml)intheabsenceorpresenceoftheFGFRinhibitorSU5402(50μM).
After5 hofincubation,cellswerelysed,andproteinswereanalysedbySDS/PAGEandWestern
blotting using antisera against MKP-3, phospho-ERK (P-ERK) and ERK.
approx. 250 bp upstream of the putative transcriptional start site
for MKP-3 (Figure 4A). This putative promoter does not contain
a TATA box, but, in common with many TATA-less promoters,
it does contain a CAAT box in the reverse (ATTG) orientation.
Interestingly,thisregionalsocontainsconsensus-bindingsitesfor
a number of different transcription factor families that occur in
all ﬁve species in the same order and orientation. These include
sites for Forkhead, the Ets family of transcription factors, NF-κB,
PBX1 (pre-B-cell leukaemia transcription factor 1)-related
homeobox factors and the SRY (sex-determining region Y)-box
containing factor SOX5 (Figure 4A). Of these, the Ets-binding
site is of particular interest as a number of Ets family members,
including Elk1 (Ets-like kinase 1), Ets1 and Ets2, are known
targets of ERK1/2 signalling [34,35]. In addition, Forkhead is a
downstreamtargetofPI3Ksignalling,andMeis1,whichcanform
complexes with PBX1, is a retinoic acid-inducible protein in the
proximal domain of the developing limb [36,37].
To perform a functional analysis of the DUSP6/MKP-3 pro-
moter, we ﬁrst isolated a 6.4 kb BamHI fragment containing
nucleotides −6758 to −359 (where the A of the ATG start
codon is +1) of the 5
  ﬂanking sequence from the murine gene.
This included the putative transcriptional start site and approx.
100 bp of the 5
 -UTR (untranslated region). This was cloned into
a luciferase-reporter construct, and, following transfection into
NIH 3T3 cells, transcriptional activity was assayed in either the
absenceorpresenceofFGF2,FGF4orFGF8(Figures4Band4C).
A robust increase in promoter activity was seen in response to all
three FGFs. We then performed a deletion analysis of this FGF-
responsive promoter. Reporter constructs containing sequences
from −1368 to −359 (1010 bp), −866 to −359 (508 bp), −755
to −359 (397 bp), −700 to −359 (342 bp) and −655 to −359
(297 bp) demonstrated an increased transcriptional response
following exposure of cells to FGFs. In contrast, reporters
containing sequences from −605 to −359 (247 bp) and −550 to
−359 (192 bp) were completely unresponsive to FGF treatment
(Figures 4B and 4C). Interestingly, the 50 bp interval between
constructs297and247fallswithintheconservedregionidentiﬁed
in our in silico promoter analysis, indicating that it contains
regulatorysequencesessentialforFGF-inducibleDUSP6/MKP-3
transcription.
FGF-dependent DUSP6/MKP-3 reporter activity is mediated by
activation of ERK and not by activation of the PI3K pathway
We next assessed whether FGF-responsive DUSP6/MKP-3 tran-
scription was dependent on signalling through either the ERK or
the PI3K pathway. The 508 bp DUSP6/MKP-3 reporter (nucleo-
tides −866 to −359) was selected for these experiments as this is
both FGF-responsive and contains the whole of the conserved
region identiﬁed in our in silico analysis which includes the
putative Forkhead-, Ets- and NF-κB-binding sites. This plasmid
was transfected into NIH 3T3 cells, which were then stimulated
with FGF2, FGF4 or FGF8 either in the absence or presence of
PD184352 or LY294002. FGF-inducible promoter activity was
strongly inhibited by the MEK inhibitor PD184352, while being
refractory to inhibition of PI3K signalling (Figure 5A). Similar
results were obtained with the longer (6400 bp) reporter construct
containing nucleotides −6758 to −359 (results not shown). In
an alternative approach, we co-transfected the 508 bp reporter
with either MEK-EE, a constitutively active mutant of MKK,
aloneortogetherwithhumanDUSP6/MKP-3itself.Theactivated
form of MKK caused a signiﬁcant increase in reporter activity
and this was abrogated by co-expression of DUSP6/MKP-3.I n
this regard, our MKP-3 promoter behaved similarly to a model
ERK-responsive transcriptional readout in the form of a GAL4-
dependent luciferase reporter co-transfected with a GAL4–Elk1
fusion protein (Figure 5B). Finally, we transfected  -Raf-1:ER*
NIH 3T3 cells with the 508 bp reporter and stimulated these cells
with either FGF4 or 4-HT. Both agonists caused a signiﬁcant
increaseinDUSP6/MKP-3reporteractivity,andthiswasblocked
by the MEK inhibitor PD184352, but not by the PI3K inhibitor
LY294002 (Figure 5C). We conclude that the FGF-dependent
activation of the DUSP6/MKP-3 gene promoter is dependent on
the activation of ERK1/2, but not PI3K, in NIH 3T3 cells and
that this activity accurately reﬂects the ERK-dependence of FGF-
mediated induction of both endogenous DUSP6/MKP-3 protein
and mRNA.
ERK-dependent DUSP6/MKP-3 transcription requires a conserved
Ets-binding site
As noted previously, the region of the DUSP6/MKP-3 promoter
identiﬁed in our deletion analysis contains putative binding sites
for a number of transcription factors. Of these, the most obvious
targetforsignallingthroughtheERKpathwayisanEtssite,which
overlaps with a potential binding site for NF-κB (Figure 4A). To
investigate the importance of this sequence, we mutated the three
core bases of the Ets site either singly or in combination within
the context of the 508 bp reporter. All of these changes led to a
signiﬁcant reduction in promoter activity in response to FGF2,
FGF4 and FGF8 (Figure 6A). In addition, we noticed that the Ets
site is actually palindromic (CGGAAATTCCT) and mutation
of this second motif (TCC to GAA) also causes a signiﬁcant
reduction in DUSP6/MKP-3 promoter activity (Figure 6A).
BecausetheconservedEts-bindingsiteoverlapswithaputative
site for the NF-κB transcription factor (Figure 4A), it was
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Figure 4 Bioinformatic and functional analysis of the murine DUSP6/MKP-3 gene promoter
(A) DNA sequence alignment of a conserved region identiﬁed within the proximal promoter of the DUSP6/MKP-3 gene in vertebrates: Mm (Mus musculus), Rn (Rattus norvegicus), Hs (Homo
sapiens),Tr(Takifugurubripes),Dr(Daniorerio)andXt(Xenopustropicalis).Conservedtranscriptionfactor-bindingsitesareboxed,eithergrey-lined(forwardstrand)orblackbroken-lined(reverse
strand) and identiﬁed as follows: FKHD(Forkheadfamily), ELK1 (Ets-binding site), NF-κB, PBXC (PBX1–Meis1 complexes),HNF1 (hepaticnuclear factor 1), SOX5 [Sox/SRY-sex/testis determining
and related HMG (high-mobility group) box factors], RFX1 (regulatory factor X1), CAAT box (CAAT box: promoter element in some genes located approx. 75–80bp upstream of the start site for
transcription). Core bases are shown in bold, and, where these overlap, the nucleotides belonging to each site are identiﬁed to indicate orientation (either bold grey or hatched underlined). The
putativetranscriptionalstartsiteisalsoindicated(boxedinblack).Thelatterisbasedonmappingthe5 -mostextentofannotatedESTs(expressedsequencetags)forDUSP6/MKP-3.(B)Schematic
diagramshowingthe5  boundariesoftheDUSP6/MKP-3 promoter–reporterconstructsemployedinthedeletionanalysis.NucleotidesarenumberedwiththeAoftheATGstartcodondesignatedas
+1. The putative transcriptional start site (−463) is indicated as are the BamHI restriction enzyme sites used to subclone the longest (6400bp) genomic fragment into the ﬁreﬂy luciferase reporter
plasmid. The position of the conserved region containing the putative transcription factor-binding sites is also indicated. (C) The constructs indicated in (B) were co-transfected into NIH 3T3 cells
along with pRL-TK Renilla to normalize for transfection efﬁciency. Cells were then starved overnight in 0.5% serum. The following day, cells were either left untreated or stimulated with the indicated
FGF (all at 30ng/ml) for an additional 24h, before cells were lysed, and luciferase assays were performed. pGL3Basic acted as a negative (promoterless) control. Luciferase assays were performed
in quadruplicate, and results are mean+ −S.E.M. ﬁreﬂy/Renilla ratios.
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Figure 5 FGF-dependent DUSP6/MKP-3 promoter activity is mediated by
activation of ERK and not by activation of the PI3K pathway
(A) The 508bp DUSP6/MKP-3 reporter construct was co-transfected into NIH 3T3 cells along
withpRL-TKRenilla tonormalizefortransfectionefﬁciency.Cellswerethenstarvedovernightin
0.5% serum. The following day, cells were either left untreated or stimulated with the indicated
FGF (all at 30ng/ml) in either the absence or the presence of vehicle (DMSO), PD184352
(2 μM) or LY294002 (10μM) for an additional 24h. Cells were then lysed, and luciferase
assayswereperformedinquadruplicate.(B)Eitherthe508bpDUSP6/MKP-3 reporterconstruct
or a plasmid encoding a GAL4–Elk1 fusion protein together with a GAL4-dependent luciferase
reporter(Luc/Elk)wasco-transfectedintoNIH3T3cellsalongwithpRL-TKRenilla tonormalize
for transfection efﬁciency and either empty pSG5 expression vector or pSG5 encoding either a
constitutively active mutant of MEK (MEK-EE) or DUSP6/MKP-3 itself. After 24h, cells were
lysed, and luciferase assays were performed in quadruplicate. (C)  -Raf-1:ER* NIH 3T3 cells
were co-transfected with the 508bp DUSP6/MKP-3 reporter construct and pRL-TK Renilla to
normalize for transfection efﬁciency. Cells were then serum-starved overnight and either left
untreated or treated with either FGF4 (30ng/ml) or 4-HT (100nM) in the presence or absence
of vehicle (DMSO), PD184352 (2 μM) or LY294002 (10μM). After 24 h, cells were lysed, and
luciferase assays were performed in quadruplicate. Results are mean+ −S.E.M. ﬁreﬂy/Renilla
ratios.
importanttoinvestigateapossibleroleforthissignallingpathway
in mediating the response to FGF. We ﬁrst determined whether
expression of a dominant-negative mutant of IκBα (Mad3 super-
repressor) affected the FGF-mediated activation of the DUSP6/
MKP-3 promoter. Co-expression of this protein had no effect
on FGF-inducible DUSP6/MKP-3 transcription (Figure 6B). In
addition, an NF-κB-responsive reporter containing three NF-κB-
binding sites (3× κB) was completely unresponsive to FGF. In
contrast,TNFα(tumournecrosisfactorα)stimulatedthisreporter,
and its activity was completely inhibited by co-expression of the
Mad3 super-repressor (Figure 6B). Finally, a putative site for
the Forkhead (FOXO) family of transcription factors lies
within the 5
  boundary of our FGF-responsive 297 bp DUSP6/
MKP-3 reporter. However, mutation of this site within our
Figure 6 A conserved Ets-binding site is required for FGF-inducible
DUSP6/MKP-3 promoter activity
(A) NIH 3T3 cells were co-transfected with either the wild-type 508bp DUSP6/MKP-3 reporter
construct or the indicated mutants together with pRL-TK Renilla to normalize for transfection
efﬁciency. Cells were then starved overnight in 0.5% serum. The following day, cells were
either left untreated or stimulated with the indicated FGF (all at 30ng/ml). After 24h, cells
were lysed, and luciferase assays were performed in quadruplicate. (B) NIH 3T3 cells were
co-transfectedwiththeindicatedreporterconstructsalongwitheitherRSV-Mad3(20or100ng)
orasacontrolRSV-βGalandpRL-TKRenilla tonormalizefortransfectionefﬁciency.Cellswere
then serum-starved overnight (0.5% FBS) and either left untreated or exposed to either FGF4
(30ng/ml) for 24h or TNFα (10ng/ml) for 6 h. Cells were then lysed, and luciferase assays
wereperformedinquadruplicate.(C)NIH3T3cellswereco-transfectedwitheitherthewild-type
508bp DUSP6/MKP-3 reporter construct or a 508bp reporter in which the Forkhead-binding
site was mutated (FKHD) together with pRL-TK Renilla to normalize for transfection efﬁciency.
Cellswerethenstarvedovernightin0.5%FBS.Thefollowingday,cellswereeitherleftuntreated
orstimulated with theindicatedFGF(allat30ng/ml)either in theabsence(DMSO)or presence
of PD184352 (2 μM). After 24h, cells were lysed, and luciferase assays were performed in
quadruplicate. Results are mean+ −S.E.M. ﬁreﬂy/Renilla ratios.
508 bp reporter had no effect on FGF-mediated activation, and
transcriptional activity remained sensitive to inhibition of the
ERK1/2MAPKpathwaybyPD184352(Figure6C).Weconclude
that a functional Ets site is required for FGF-inducible DUSP6/
MKP-3 transcription and that neither NF-κB nor Forkhead plays
a role in mediating this response.
ERK-responsive transcription factors Ets1 and Ets2 bind to the
endogenous DUSP6/MKP-3 gene promoter
Our results thus far implicate a member or members of the
Ets group of transcription factors in mediating ERK-dependent
DUSP6/MKP-3transcriptioninresponsetoFGFs.Toexplorethis
further, we performed EMSAs using a labelled double-stranded
oligonucleotide probe spanning the conserved Ets site (MKP-3).
These experiments revealed a speciﬁc protein complex, which
was not seen when labelled mutant oligonucleotide (MKP-3m) is
usedasaprobe(Figure7A).Thiscomplexiseffectivelycompeted
awaybyunlabelledwild-typeMKP-3oligonucleotide(M),butnot
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Figure 7 Ets-family transcription factors bind to the endogenous DUSP6/MKP-3 gene promoter
(A) EMSAs were performed using the following labelled oligonucleotide probes: wild-type MKP-3 or an Ets site mutant MKP-3 (MKP-3m), and wild-type canonical Ets-binding site (E74) or its
corresponding Ets-binding site mutant (E74m). Labelled probes were then incubated with nuclear extract from NIH 3T3 cells in either the absence or the presence of the following unlabelled
competitor DNAs: wild-type MKP-3 (M), mutant MKP-3 (m), wild-type E74 (E) or the corresponding Ets site mutant (e). Following incubation, mobility-shifts were visualized by electrophoresis and
autoradiography. (B) ChIP assays were performed using an unrelated control antibody (HA) and antibodies speciﬁc for Ets1, Ets2 or ERM81. Speciﬁc PCR products corresponding to the region
of the DUSP6/MKP-3 promoter containing the putative Ets-binding site and the non-speciﬁc control reactions are shown, as are the controls lacking template and the results of PCRs performed
using the input chromatin as template. (C) NIH 3T3 cells were either transfected with the 508bp DUSP6/MKP-3 reporter alone or together with either a deletion mutant of Ets2 lacking a functional
DNA-binding domain (Ets2 DBDmut), a mutant Ets2 protein lacking a conserved MAPK phosphorylation site (Ets2 T72A) or wild-type Ets2. Following transfection, cells were cultured overnight in
medium containing 10% FBS. Cells were then lysed, and luciferase assays were performed in triplicate. Results are mean+ −S.E.M. ﬁreﬂy/Renilla ratios.
by a mutant oligonucleotide with a single substitution in the Ets
site(m).Thiscomplexisalsoeffectivelycompetedbyawild-type
(E) but not a mutant (e) oligonucleotide containing a canonical
Ets-binding site. A complex that co-migrated with that seen using
thewild-typeMKP-3oligonucleotide,wasalsoobservedusingthe
wild-type canonical Ets site (E74), but not a mutant
oligonucleotide(E74m)asaprobe(Figure7A).Thiscomplexwas
competed away by both wild-type Ets (E) oligonucleotide and,
albeit less effectively, by the wild-type MKP-3 oligonucleotide
(M).Furtherexperimentsshowedthatthecomplexdetectedusing
the MKP-3 oligonucleotide was present when nuclear extracts
from either control or FGF-treated cells was used, indicating that
protein(s) may be constitutively bound to the DUSP6/MKP-3
promoter (results not shown). With this information in hand, we
decided to take a candidate approach to examine the binding of
individualEtsfactorstotheendogenousDUSP6/MKP-3promoter
using ChIP assays.
For these experiments, NIH 3T3 cells were cultured in 10%
serum before treatment with 1% formaldehyde for 10 min to
cross-linkDNAandproteinsinvivo,followedbycelllysisandthe
preparation of chromatin. Chromatin from approx. 2×10
7 cells
was sonicated to an average length of 600 bp before immunopre-
cipitation with either a non-speciﬁc (HA) antibody or speciﬁc
antisera against Ets factors. Precipitated DNA was ampliﬁed by
PCR, separated by agarose gel electrophoresis, and visualized
by ethidium bromide staining (Figure 7B). Two sets of oligo-
nucleotide PCR primers were used, one of which was speciﬁc
for the Ets-binding site and, as a control, primers that annealed
to sequences upstream of the Ets-binding site. Non-precipitated
(input) chromatin was a positive control for these PCRs. We
could detect signiﬁcant association of both Ets1 and Ets2 with
the Ets-binding site, whereas no detectable signal was seen using
either the control antibody or an antibody against ERM81, a
member of the closely related Pea3 subfamily of Ets factors.
Additional ChIP experiments using antibodies speciﬁc for Elk1
also resulted in a failure to detect binding to the DUSP6/MKP-
3 promoter (results not shown). Finally, we assessed the impact
of expressing wild-type and mutant forms of Ets2 on the activ-
ity of the 508 bp DUSP6/MKP-3 luciferase reporter. Co-trans-
fection of wild-type Ets2 caused a signiﬁcant increase in reporter
activity. In contrast, co-expression of either a deletion mutant
of Ets2 ( 410–425) lacking a functional DNA-binding domain
(Ets2 DBDmut) or a mutant form of Ets2 (Ets2 T72A) lacking
a critical MAPK phosphorylation site [38] did not increase
DUSP6/MKP-3 reporter activity (Figure 7C).
The murine DUSP6/MKP-3 promoter is regulated appropriately by
endogenous signals which depend on the FGF/MAPK pathway
To test whether the 508 bp fragment of the DUSP6/MKP-3
promoter is appropriately activated in the context of a developing
embryo, we placed this sequence into a reporter construct driving
expression of destabilized EGFP (508ptkd2EGFP) [23]. HH10
(ten somite) embryos (Figure 8A) were then co-electroporated
withthisplasmidandaplasmidencodingCMV(cytomegalovirus)
promoter-driven mRFP (monomeric red ﬂuorescent protein)
(CAGmRFP), which identiﬁes all electroporated cells. At this
stage DUSP6/MKP-3 is expressed in the caudal neural plate, a
region of high ERK1/2 activity, but not more rostrally in the
c   The Authors Journal compilation c   2008 Biochemical Society © 2008 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.Feedback regulation of FGF signalling by DUSP6/MKP-3 295
Figure 8 The 508 bp DUSP6/MKP-3 promoter fragment directs transgene expression in an endogenous DUSP6/MKP-3 domain
(A) Schematic diagram of the HH10 chick embryo. The boxed area indicates approximate ﬁeld in (B–I). (B) Comparison of ERK1/2 phosphorylation and DUSP6/MKP-3 mRNA expression in the
caudal region of the HH10 chick embryo. dpErk1/2, dual-phosphorylated ERK1/2. (C) HH10 chick embryo co-electroporated with a plasmid constitutively expressing mRFP (CAGmRFP) and
the 508bp fragment of the DUSP6/MKP-3 promoter driving expression of EGFP (508ptkd2EGFP) only within the endogenous DUSP6/MKP-3 domain. (D) Embryo co-electroporated with plasmid
508ptkd2EGFPin whichtheEts-binding siteis mutated (EtsMut1)and CAGmRFPshowsreducedEGFP expression.(E) Co-electroporationofplasmid 508ptkd2EGFPin whichtheForkhead-binding
site is mutated (FKHDMut1) and CAGmRFP. (F–H). Embryos were co-electroporated with the wild-type DUSP6/MKP-3 promoter fragment (508ptkd2EGFP) and CAGmRFP before beads were
soaked in DMSO (F), 5mM SU5402 (G), 20mM PD184352 (H) or 20mM LY294002 (I) were placed next to the electroporation site. Both SU5402 and PD184352 cause a local down-regulation
of DUSP6/MKP-3 promoter activity. In contrast, neither LY294002 nor DMSO alone have any signiﬁcant effect on DUSP6/MKP-3 promoter activity. Asterisks (*) indicates grafted bead, and the
arrowhead indicates the position of the last formed somite. nt, neural tube; cnp, caudal neural plate; som, somite.
neural tube ﬂanked by somites (Figures 8A and 8B) [26]. Intro-
duction of these constructs into the neuroepithelium revealed that
this DUSP6/MKP-3 promoter region drives EGFP expression
within the endogenous DUSP6/MKP-3 domain (where cells co-
expressed EGFP and mRFP) and not in the rostral neural tube,
where only mRFP was detected (after 4–6 h of incubation)
(Figure 8C, 14 of 14 cases). This 508 bp sequence is thus
sufﬁcient to recapitulate the expression pattern of the endogenous
DUSP6/MKP-3 gene. When the Ets-binding site is mutated,
expression of EGFP is either much reduced (Figure 8D, six of
11 cases) or absent (ﬁve of 11 cases). In contrast, mutation of the
putative Forkhead-binding site does not reduce EGFP expression
(Figure 8E, six of six cases).
We next tested whether the 508 bp DUSP6/MKP-3 promoter
fragment is regulated by FGF-mediated ERK1/2 activation in
caudal neural tissue. Embryos were co-electroporated with the
508ptkd2EGFP and CAGmRFP constructs, then cultured in
the presence of locally applied beads soaked in either DMSO
vehicle control (Figure 8F), the FGFR inhibitor SU5402 (Fig-
ure 8G) or the MEK inhibitor PD184352 (Figure 8H) (see the
Experimentalsection).BlockingactivationofeitherFGFRsorjust
ERK1/2inhibitedMKP-3promoteractivity(sixofsixandeightof
eight cases respectively), whereas control beads did not attenuate
EGFP expression. Finally, to test whether the 508 bp promoter
is regulated by PI3K signalling, we electroporated embryos with
the508ptkd2EGFPandCAGmRFPconstructs,thenculturedthem
in the presence of beads soaked in the PI3K inhibitor LY294002
(Figure 8I). In all cases, there was no loss of EGFP, suggesting
that DUSP6/MKP-3 expression in the caudal neural plate is not
downstream of this signalling pathway (ﬁve of ﬁve cases).
DISCUSSION
Invertebrates,theinductionofDUSP6/MKP-3inresponsetoFGF
during early development represents the best-characterized link
between a speciﬁc growth factor signalling axis and expression
of an MKP [9,10]. However, whether DUSP6/MKP-3 induction
represents a negative-feedbackcontrol oran example of regulated
cross-talk between two intracellular signalling pathways is
controversial, as essential roles have been proposed for both
ERK MAPK and PI3K signalling in regulating DUSP6/MKP-3
expression [10–13,15]. The majority of these data were obtained
usingtwodifferentpharmacologicalinhibitorsofMEK(PD98059
or PD184352) and LY294002, a speciﬁc inhibitor of PI3K.
Furthermore, chemicals were delivered by implantation of beads
pre-soaked in 10–20 mM solutions of drug into chicken embryos
[10,11]. This makes the effective concentrations of inhibitor
delivered to tissues difﬁcult to assess and raises questions about
both the potency and speciﬁcity of pathway inhibition in these
studies [16]. In the present study, we have utilized cultured NIH
3T3 cells to study FGF-inducible expression of DUSP6/MKP-3,
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allowing a more precise delivery of drug and direct biochemical
readout of its effects.
Our results clearly show that FGF treatment of NIH 3T3
ﬁbroblasts induces DUSP6/MKP-3 expression at the level of both
mRNA and protein. Furthermore, although inhibition of ERK1/2
activity blocks this expression completely, we can ﬁnd no evi-
dence for the involvement of PI3K in this process. These results
are reinforced by the observation that conditional activation of
the ERK1/2 MAPK pathway in  -Raf-1:ER* NIH 3T3 cells also
increases levels of DUSP6/MKP-3 protein, indicating that ERK
activation is both necessary and sufﬁcient to trigger expression
of this phosphatase. To probe the molecular mechanism by
whichERKactivationmightinﬂuenceDUSP6/MKP-3expression
levels, we performed both a bioinformatic and a functional
analysis of the murine DUSP6/MKP-3 gene promoter.
Comparative genome analysis revealed a conserved region
within the proximal promoter of MKP-3/DUSP6 containing
a number of transcription factor-binding sites. This analysis
included sequences from mammal, amphibian and ﬁsh genomes.
Most of the work performed previously to analyse the signalling
pathways involved in the regulation of DUSP6/MKP-3 by FGF
has been performed in chicken embryos [10,11]. However, we
were unable to include the chicken DUSP6/MKP-3 homologue in
our analysis, as the 5
 -ﬂanking region of the gene is lacking from
the current genome sequence release (http://www.ensembl.org/
Gallus_gallus/index.html).
Of the putative regulatory elements within this conserved
region, the most obvious candidate with respect to an interface
with the ERK MAPK pathway is a conserved Ets-binding site.
Many growth factor-activated genes such as c-Fos are regulated
by SRF (serum-response factor), a MADS-box transcription fac-
tor. SRF forms a ternary complex with Ets family members such
as Elk1, also known as TCFs (ternary complex factors), whose
activityiscontrolledbyMAPKsignalling[34,39].However,close
examination of the DUSP6/MKP-3 promoter reveals no cognate
binding sites for SRF, indicating that the Ets site is functioning
autonomously.
We can detect the constitutive binding of protein(s) to this Ets
consensus sequence in EMSAs and, by using ChIP analysis, the
EtsfamilyproteinsEts1andEts2werefoundtobeassociatedwith
this binding site in vivo. The latter observation provides a mech-
anistic link between DUSP6/MKP-3 transcription and ERK1/2
activity. The observation that two distinct Ets family members
can associate with the DUSP6/MKP-3 promoter in NIH 3T3 cells
also raises questions of binding speciﬁcity. A recent genome-
wide analysis of Ets protein binding revealed unexpected levels
of redundant occupancy [40]. Furthermore, this degree of redun-
dancy was increased if the Ets-binding site was proximal to the
transcriptional start site, as is the case in DUSP6/MKP-3.T h eE t s
site within DUSP6/MKP-3 is also palindromic, and core bases
within both half-sites are required for FGF-responsive DUSP6/
MKP-3 transcription. Interestingly, the stromelysin-1 gene pro-
moter also contains a head-to-head Ets-binding site palindrome
[41]. This site has recently been demonstrated to mediate
stromelysin-1 expression in response to the tumour promoter
PMA,andtheEts1transcriptionfactorisfoundtobeconstitutively
associated with this site in vivo [42]. It will be interesting to
explore further mechanistic similarities in the regulation of these
two growth factor-regulated genes, both of which involve the Ets
family of transcription factors acting independently of SRF as a
conduit for ERK1/2 signalling.
TheexpressionoftheDUSP6/MKP-3geneinresponsetotissue
sources of FGF is observed in mouse, chicken and zebraﬁsh
embryos, and this is probably a reﬂection of the conservation
of the regulatory sequences revealed by our promoter analysis.
Scanning genomic fragments for enhancer activity utilizing
embryo electroporation in the chicken can identify such regions.
Thismethodmakesuseofreporterconstructsinwhichexpression
of EGFP is driven by DNA sequences from the locus of interest
[23]. Using this approach, we have clearly shown that the re-
gion of the murine DUSP6/MKP-3 promoter encompassing the
conserved Ets-binding site recapitulates the endogenous domain
of DUSP6/MKP-3 expression in chicken embryo caudal neural
tissue. Furthermore, this expression is dependent on the integrity
of the Ets-binding site and is sensitive to inhibition of the ERK
MAPK pathway. We have identiﬁed Ets1 and Ets2 as binding to
the DUSP6/MKP-3 promoter in NIH 3T3 cells, and the question
arises as to their expression in the tissues we have analysed in the
presentstudy.WehavenotdeterminedthepatternofEts1andEts2
mRNA expression in the chicken embryo. However, between day
8.5 and day 10.5 of mouse embryonic development, Ets2 mRNA
is expressed in tail bud, pre-somitic mesenchyme and limb bud
mesenchyme in a pattern which is almost indistinguishable from
that which we observe for DUSP6/MKP-3 mRNA, which in turn
correlates with sites of active FGF signalling [9,43].
In conclusion, we have provided compelling evidence that
activation of the ERK MAPK pathway and not the PI3K path-
way drives expression of DUSP6/MKP-3 mRNA and protein in
responsetoFGFsinmammaliancells.This,togetherwithourpre-
vious studies in developing mouse and chicken embryos [10,16],
strongly supports the idea that DUSP6/MKP-3 performs a key
role as a negative-feedback regulator of FGF-activated ERK1/2
signalling. In addition, our functional studies of the mouse gene
promoter provide the ﬁrst evidence of a molecular mechanism
by which ERK1/2 signalling impinges on transcription factors
that are responsible for mediating DUSP6/MKP-3 expression.
DUSP6/MKP-3, along with genes such as Sprouty and Sef,
belong to the FGF synexpression group of FGF antagonists [44].
Although the FGF-inducible expression of Sprouty and Sef has
also been linked with activation of ERK1/2 [45,46], both the
mechanism by which this occurs and their mode of action as
inhibitors of FGF signalling remain unclear [47–50]. Our present
results thus make DUSP6/MKP-3 the best understood of the FGF
synexpression group in terms of a molecular mechanism for
negative-feedback control of FGF signalling. Finally, DUSP6/
MKP-3 gene expression is also reported to be responsive to other
agonists during early development, including maternal β-catenin
signalling and retinoic acid [51,52]. The tools we have developed
in the present study should facilitate a more extensive analysis
of the signalling pathways that interact with the transcription
machinery to regulate DUSP6/MKP-3 expression.
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